Clinical Trial Detail

NCT ID NCT01752400
Title AUY922 for Advanced ALK-positive NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Luminespib

Age Groups: adult

Additional content available in CKB BOOST